Results 211 to 220 of about 85,832 (295)

Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab‐soravtansine therapy

The Journal of Pathology: Clinical Research, Volume 12, Issue 3, May 2026.
Abstract Mirvetuximab‐soravtansine (MIRV‐S) is an antibody‐drug conjugate targeting folate receptor alpha (FOLR1). MIRV‐S is approved for the treatment of FOLR1‐positive, platinum‐resistant ovarian carcinoma. Patient eligibility is determined by immunohistochemistry (IHC) using a companion diagnostic (CDx) assay (FOLR1‐2.1, Ventana).
Annika Nasdala, Leonie D Kandt, Martin Radner, Nora Schaumann, Malte Gronewold, Pia Hillmann, Henriette Christgen, Jens Hachenberg, Elna Kuehnle, Christian Hartmann, Matthias Christgen   +10 more
wiley   +1 more source

Primary rectal ectopic pregnancy: a rare case report and literature review. [PDF]

Front Med (Lausanne)
Zhang Q, Yang W, Wang B.
europepmc   +1 more source

Health Economic Evaluation on Point of Care Antenatal Ultrasound in Rural and Remote Communities Globally: A Scoping Review

Australasian Journal of Ultrasound in Medicine, Volume 29, Issue 2, May 2026.
ABSTRACT Introduction There are significant global discrepancies in the provision of maternal healthcare with many women from under‐resourced countries and rural communities having inferior access to such services. Within rural and remote communities and low‐resource areas, point‐of‐care ultrasound (PoCUS) has the potential to improve health outcomes ...
Zoe Hampshire, Lucy Wood, Camille Schubert, Janine Dizon, Katherine Guerrero, Nayana Parange   +5 more
wiley   +1 more source

Rare ultrasound diagnosis of unilateral tubal twin ectopic pregnancy. [PDF]

Ultrasound
Oriaifo N, Roberts R, Kumar B, Henderson R.   +3 more
europepmc   +1 more source

CNC–PNIPAM Drug Delivery System Improves Endometrial Receptivity via Natural Killer Cell Immune Tolerance in Endometriosis

Advanced NanoBiomed Research, Volume 6, Issue 5, May 2026.
An injectable CNC–PNIPAM hydrogel is developed for intrauterine co‐delivery of levonorgestrel and botropase. This platform reprograms uterine natural killer cells toward an immune–tolerant phenotype and enhances endometrial receptivity marker expression. The results demonstrate a promising strategy to counteract endometriosis–associated infertility and
Zhou Liang, Yingjie Wang, Chenyu Bai, Pengfei Li, Xin He, Meng Ma, Xiaoying Luo, Yi Song, Yao Li, Yun Wang   +9 more
wiley   +1 more source

Clinical Presentation and Management of Omental Ectopic Pregnancy in a 23-Year-Old Patient: Integrative Case Study and Literature Review. [PDF]

Case Rep Obstet Gynecol
Terrinoni M, Palisciano M, Pauselli F, Cecconi L, Rossetti D, Di Renzo GC.   +5 more
europepmc   +1 more source

Papillary Thyroid Carcinoma Originating in a Male With Thyroglossal Duct Cyst: Case Presentation and Literature Review

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Papillary carcinoma arising in a thyroglossal duct cyst is rare and often indistinguishable from benign disease. We report a male patient with progressive cyst changes leading to diagnosis and successful Sistrunk‐based management, highlighting the need for close, appropriate imaging and individualized treatment in midline neck masses.
Nasim Abukaresh, Hossam Salameh, Tala Dweik, Anan Dawadi, Haya Taha, Sohaib Salahat, Ahmed Aljodi   +6 more
wiley   +1 more source

Ovarian Ectopic Pregnancy, an Unusual Diagnosis-Two Cases With Two Distinct Treatment Approaches. [PDF]

Clin Case Rep
Mota de Sousa A, de Pinho A, Nogueira R, Melo A, Meireles I, Soares E, do Carmo O, Castro DME.   +7 more
europepmc   +1 more source

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1179-1194, May 2026.
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley, Shakir Atoyebi, Robert Bies, Catriona Waitt, Adeniyi Olagunju   +7 more
wiley   +1 more source

Metastatic Epithelioid Trophoblastic Tumor Following Incomplete Methotrexate Therapy for Ectopic Pregnancy: A Case Report and Multimodal Management. [PDF]

Cureus
Ting R.
europepmc   +1 more source